188
Views
1
CrossRef citations to date
0
Altmetric
SHORT REPORT

Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip

, ORCID Icon, ORCID Icon, , , , , , , ORCID Icon, & show all
Pages 5839-5848 | Received 19 Mar 2022, Accepted 16 Sep 2022, Published online: 04 Oct 2022

References

  • Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020. PMID: 33333012. doi:10.1016/S1473-3099(20)30847-1
  • Dewi IM, Janssen NA, Rosati D, et al. Invasive pulmonary aspergillosis associated with viral pneumonitis. Curr Opin Microbiol. 2021;62:21–27. doi:10.1016/j.mib.2021.04.006
  • Douglas AP, Smibert OC, Bajel A, et al.; Australasian Antifungal Guidelines Steering Committee. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. 2021;51(Suppl 7):143–176. doi:10.1111/imj.15591
  • Lass-Florl C. Susceptibility testing in Aspergillus species complex. Clin Microbiol Infect. 2014;20:49–53. doi:10.1111/1469-0691.12514
  • Mortensen KI. A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. Eur J Clin Microbiol Infect Dis. 2011;30(11):1355–1363. doi:10.1007/s10096-011-1229-7
  • Van der Linden JW, Camps SM, Kampinga GA, et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis. 2013;57(4):513–520. doi:10.1093/cid/cit320
  • Mello E, Posteraro B, Vella A, et al. Susceptibility testing of common and uncommon Aspergillus species against Posaconazole and other mold-active antifungal azoles using the Sensititre method. Antimicrob Agents Chemother. 2017;61(6):e00168–17. doi:10.1128/AAC.00168-17
  • Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID- ECMM_ERS guideline. Clin Microbiol Infect. 2018;24 Suppl 1(Suppl 1):e1–38. doi:10.1016/j.cmi.2018.01.002
  • Siopi M, Pournaras S, Meletiadis J. Comparative evaluation of Sensititre YeastOne and CLSI M38-A2 reference method for antifungal susceptibility testing of Aspergillus spp. against echinocandins. J Clin Microbiol. 2017;55(6):1714–1719. doi:10.1128/JCM.00044-17
  • Wang H-C, Hsieeh M-I, Choi P-C, Wu C-J. Comparison of the Sensititre YeastOne and CLSI M38-A2 microdilution methods in determining the activity of amphotericin B, itraconazole, voriconazole, and posaconazole against Aspergillus species. J Clin Microbiol. 2018;56(10):e00780–18. doi:10.1128/JCM.00780-18
  • Lamoth F, Alexander BD. Comparing Etest and broth microdilution for antifungal susceptibility testing of the most-relevant pathogenic molds. J Clin Microbiol. 2015;53(10):3176–3181. doi:10.1128/JCM.00925-15
  • ThermoFisher Scientific. Thermo Scientific Sensititre Plate Guide for Antimicrobial Susceptibility Testing. Available from: https://assets.thermofisher.com/TFS-Assets/MBD/brochures/Sensititre-Plate-Guide-Booklet-EN.pdf Accessed 28 September 2022.
  • © Liofilchem®. MIC test strip technical sheet Isavuconazole - MTS40 - Rev.0; 2015.
  • Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, et al. Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the sensititre YeastOne colorimetric broth and etest agar diffusion methods. Antimicrob Agents Chemother. 2018;63(1):e01651. doi:10.1128/AAC.01651-18
  • Espinel-Ingroff A, Arendrup M, Cantón E, et al. Multicenter study of method-dependent epidemiological cutoff values for detection of resistance in Candida spp. and Aspergillus spp. to Amphotericin B and echinocandins for the Etest agar diffusion method. Antimicrob Agents Chemother. 2016;61(1):e01792–16. doi:10.1128/AAC.01792-16
  • Egger M, Bussini L, Hoenigl M, Bartoletti M. Prevalence of COVID-19-Associated pulmonary Aspergillosis: critical review and conclusions. J Fungi. 2022;8(4):390. PMID: 35448621; PMCID: PMC9027069. doi:10.3390/jof8040390
  • Risum M, Hare RK, Gertsen JB, et al. Azole resistance in Aspergillus fumigatus. The first 2-year’s data from the Danish National surveillance study, 2018–2020. Mycoses. 2022;65(4):419–428. PMID: 35104010; PMCID: PMC9302650. doi:10.1111/myc.13426
  • Guinea J. Updated EUCAST clinical breakpoints against Aspergillus, implications for the clinical microbiology laboratory. J Fungi. 2020;6(4):343. doi:10.3390/jof6040343
  • Trovato L, Scalia G, Palermo CI, Costanzo CM, Oliveri S. Evaluation of isavuconazole MIC strips for susceptibility testing of Aspergillus and Scedosporium species. Med Mycol. 2019;57(4):429–433. doi:10.1093/mmy/myy071
  • Lackner N, Vahedi-Shahandashti R, Jähnig S, Schönherr L, Lass-Flörl C. Echinocandins and their activity against aspergillus terreus species complex: a novel agar screening method. Antimicrob Agents Chemother. 2022;66(2):e0190921. PMID: 34902268; PMCID: PMC8846437. doi:10.1128/AAC.01909-21
  • Meletiadis J, Siopi M, Kanioura L, et al. Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species. J Antimicrob Chemother. 2019;74(8):2247–2254. PMID: 31106352; PMCID: PMC6640300. doi:10.1093/jac/dkz154
  • Idelevich EA, Groß U, Becker K, Bader O. Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2018;91(1):52–54. PMID: 29422272. doi:10.1016/j.diagmicrobio.2018.01.003
  • Nargesi S, Jafarzadeh J, Najafzadeh MJ, et al. Molecular identification and antifungal susceptibility of clinically relevant and cryptic species of Aspergillus sections Flavi and Nigri. J Med Microbiol. 2022;71(4). PMID: 35451946. doi:10.1099/jmm.0.001480
  • Nematollahi S, Permpalung N, Zhang SX, Morales M, Marr KA. Aspergillus lentulus: an under-recognized cause of antifungal drug-resistant Aspergillosis. Open Forum Infect Dis. 2021;8(8):ofab392. PMID: 34466628; PMCID: PMC8403229. doi:10.1093/ofid/ofab392
  • Astvad KMT, Hare RK, Arendrup MC. Evaluation of in vitro activity of Isavuconazole and comparator Voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates. Clin Microbiol and Infect. 2017;23(11):882–887. doi:10.1016/j.cmi.2017.03.023